FutuRx
Zeev Zehavi is Vice President of Venture Investments for Johnson & Johnson Innovation – JJDC, Inc. (JJDC) and joined in 1999. He is based out of offices in Israel.
Zeev’s background covers an extensive array of health care and related businesses. He spent over 10 years with Teva Pharmaceutical Industries, Ltd., including a five-year assignment as President of the bulk chemical business in North America. He returned to Israel as President of Clal Pharmaceutical Industries (CPI) for four years.
Zeev holds a Bachelor of Science from the Hebrew University of Jerusalem and a Master of Business Administration in Marketing and Finance from Tel Aviv University. He is fluent in Hebrew, English, and Arabic.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
FutuRx
FutuRx is a biotech incubator founded by three leading global healthcare players. FutuRx leverages its access to the Israeli biotech industry, and to leading research institutes in Israel and worldwide, to identify and develop highly innovative technologies. Experts at Takeda, J&J, and OrbiMed are deeply involved in the project selection process and during the incubator period of each company. The result is a clear impact on the efficient translation of innovative research to clinically meaningful products.